期刊文献+

不同剂量温阳强心方治疗慢性充血性心力衰竭的临床疗效及对ANP的影响 被引量:5

Clinical study of Wenyang Qiangxin decoction in different doses on chronic congestive heart failure and effect of it on ANP
下载PDF
导出
摘要 目的研究不同剂量温阳强心方对慢性充血性心力衰竭心气(阳)虚、水饮泛滥证患者症状、心功能参数及ANP等的影响。方法将60例慢性充血性心力衰竭心气(阳)虚、水饮泛滥证患者随机分为两组,对照组30例,治疗组30例,两组患者均在控制基础疾病的同时,按慢性心力衰竭西医基础治疗。轻、重剂量组在此基础上分别予温阳强心方:附片用量分别为10、25 g,干姜用量分别为10、25 g,并加用红参、茯苓、甘草等。两组疗程均为3周。观察治疗前后中医临床症状、心功能参数及ANP等的变化。结果 (1)两组患者的临床症状均有明显改善(P<0.01),治疗组症状的改善明显优于对照组(P<0.05)。(2)治疗后两组患者的左室短径缩短率(FS)、射血分数(EF)、舒张早期最大充盈速度(E)、舒张晚期最大充盈速度(A)之比值(E/A)均有提高(P<0.01),治疗组以上指标的升高优于对照组(P<0.05)。(3)治疗后两组心房利钠肽(ANP)、内皮素(ET)、一氧化氮(NO)、去甲肾上腺素(NE)均有降低(P<0.01),治疗组以上指标的降低优于对照组(P<0.05)。结论轻、重剂量组的附片经充分煎煮后无明显不良反应。不同剂量温阳强心方可改善慢性充血性心力衰竭心气(阳)虚、水饮泛滥证患者症状、提高其心功能及降低ANP等。重剂量组疗效优于轻剂量组。重剂量温阳强心方是治疗慢性充血性心力衰竭的有效方剂。 Objective To study the effects of Wenyang Qiangxin decoction(WQD) in light and strong doses on symptoms,heart function and ANP of the patients with chronic congestive heart failure in syndromes of heart yang qi deficiency and damp-water flooding.Methods All 60 patients with the disease and syndrome were randomly divided in-to control group and treatment group,30 patients per group and treated.On the basic treatment with the western medicine,the patients in light and strong doses groups were given WQD re-spectively,monkshood dosage in light and strong doses was 10 g and 25 g,dry ginger was 10g and 25 g respectively,and add red ginseng,Poria,licorice,etc.The treatment lasted 3 weeks.The clinical symptoms,cardiac function parameters and ANP and other changes were measured.Results The clinical symptoms in both groups were significantly improved(P0.01),which was significantly improved in treatment group than that in control group(P0.05).After treatment,all the short axis shortening in left ventricular(FS),ejection fraction(EF),the ratio(E/A) of maximum early diastolic filling velocity(E) and maximum late diastolic filling velocity(A) in both were increased(P0.01),all of them in treatment groups were more than that in control group(P0.05).After the treatment,atrial natriuretic peptide(ANP),endothelin(ET),nitric oxide(NO),norepinephrine(NE) were lower(P0.01),all of them in the treatment groups were lower than that in control group(P0.05).Concliusion WQD in both light and strong doses can improve the symptoms of the patients with chronic congestive heart failure in syndromes of heart yang qi deficiency and damp-water flooding,enhance function and reduce ANP;strong dose is better than light dose.The monkshood,in light or strong doses,through lasted decocting,is no obvious adverse reactions,so,the strong dose of WQD is effective therapy for chronic congestive heart failure.
出处 《湖南中医药大学学报》 CAS 2010年第5期48-51,共4页 Journal of Hunan University of Chinese Medicine
基金 湖南省卫生厅中医药专项基金(2008061)
关键词 慢性充血性心力衰竭 温阳强心方 心房利钠肽 内皮素 一氧化氮 去甲肾上腺素 Wenyang Qiangxin decoction chronic congestive heart failure atrial natriuretic peptide endothelin nitric oxide norepinephrine
  • 相关文献

参考文献8

二级参考文献11

共引文献204

同被引文献48

  • 1王扬,陈希芬,杜立建.中医药治疗慢性心力衰竭临床研究进展[J].河北中医,2007,29(9):858-860. 被引量:8
  • 2张静,李庚山,李国草,周青,李文强.兔阿霉素心衰模型的建立[J].心脏杂志,2004,16(5):437-439. 被引量:29
  • 3王琦.9种基本中医体质类型的分类及其诊断表述依据[J].北京中医药大学学报,2005,28(4):1-8. 被引量:1984
  • 4赵玉兰,杨树涵,程劲松,梅峻,杨孟选.辛伐他汀对慢性心力衰竭大鼠白介素-18白介素-10的影响[J].医药论坛杂志,2007,28(10):42-43. 被引量:4
  • 5陈奎.温阳化瘀汤对难治性心力衰竭病人心功能的影响[J].中西医结合心脑血管病杂志,2007,5(8):676-677. 被引量:2
  • 6Parissisj T, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression[J]. Am J Cardiol, 2004,94(10): 1326-1328.
  • 7Ledoux J, Gee DM, Leblano N. Increased peripheral resistance in heart failure new evidence suggests an alteration in vascular smooth muscle function[J]. Br J Pharmacol, 2003, 139(7): 1245-1248.
  • 8Mcmurray JJ, Adamopoulos S, Anker SD,et al.ESC guide- lines for the diagnosis and treatment of acute and chronic heart failure 2012:the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collabora- tion with the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail,2012, 14(8) :803-869.
  • 9De Ferrari GM,Crijns HJ,Borggrefe M,et aLChronic va- gus nerve stimulation:a new and promising therapeutic approach for chronic heart failure[J].Eur Heart J, 2011,32 (7) : 847-855.
  • 10Piepoli MF,Guazzi M,Boriani G,et al.Exercise intolerance in chronic heart failure: mechanisms and therapies.Part I [J].Eur J Cardiovasc Prev Rehabil,2010,17 (6) :637- 642.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部